Literature DB >> 27679413

What are the Considerations in Balancing Benefits and Risks in Iron Treatment?: The Benefits of Intravenous Iron.

Jay B Wish1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27679413     DOI： 10.1111/sdi.12552

Source DB:  PubMed          Journal:  Semin Dial        ISSN： 0894-0959            Impact factor:   3.455


× No keyword cloud information.
  3 in total

Review 1.  Ferric Carboxymaltose: A Review in Iron Deficiency.

Authors:  Lesley J Scott
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

2.  Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents.

Authors:  Volker H Haase; Glenn M Chertow; Geoffrey A Block; Pablo E Pergola; Emil M deGoma; Zeeshan Khawaja; Amit Sharma; Bradley J Maroni; Peter A McCullough
Journal:  Nephrol Dial Transplant       Date:  2019-01-01       Impact factor: 5.992

3.  Ethnicity evaluation of ferric pyrophosphate citrate among Asian and Non-Asian populations: a population pharmacokinetics analysis.

Authors:  Lingxiao Zhang; Liangying Gan; Kexin Li; Panpan Xie; Yan Tan; Gang Wei; Xiaojuan Yuan; Raymond Pratt; Yongchun Zhou; Ai-Min Hui; Yi Fang; Li Zuo; Qingshan Zheng
Journal:  Eur J Clin Pharmacol       Date:  2022-06-17       Impact factor: 3.064
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.